Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Raft-Eze liquid
0101021B0BLAAAH
|
Raft-Eze | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Ralgex cream
1003020T0BNAAA0
|
Ralgex Heat Cream | Nicotinates | Musculoskeletal and Joint Diseases | No data available |
|
Ralgex Freeze spray
1003020Y0BEAAA0
|
Ralgex Freeze Spray | Freeze sprays and gels | Musculoskeletal and Joint Diseases | No data available |
|
Ralgex Heat spray
1003020N0BLADAZ
|
Ralgex Heat Spray/Stick | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Ralgex sticks
1003020N0BLACA0
|
Ralgex Heat Spray/Stick | Methyl salicylate | Musculoskeletal and Joint Diseases | No data available |
|
Raltegravir 100mg chewable tablets
0503010AEAAABAB
|
Raltegravir | Raltegravir | Infections | No data available |
|
Raltegravir 100mg granules for oral suspension sachets
0503010AEAAADAD
|
Raltegravir | Raltegravir | Infections | No data available |
|
Raltegravir 25mg chewable tablets
0503010AEAAACAC
|
Raltegravir | Raltegravir | Infections | No data available |
|
Raltitrexed 2mg powder for solution for infusion vials
0801030Z0AAAAAA
|
Raltitrexed | Raltitrexed | Malignant Disease and Immunosuppression | No data available |
|
Ramipril 750micrograms/5ml oral liquid
0205051R0AAAJAJ
|
Ramipril | Ramipril | Cardiovascular System | No data available |
|
Ramucirumab 100mg/10ml solution for infusion vials
0801050BZAAAAAA
|
Ramucirumab | Ramucirumab | Malignant Disease and Immunosuppression | No data available |
|
Ramucirumab 500mg/50ml solution for infusion vials
0801050BZAAABAB
|
Ramucirumab | Ramucirumab | Malignant Disease and Immunosuppression | No data available |
|
Ranclav 125mg/31mg/5ml SF oral suspension
0501013K0BDADAD
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranclav 250mg/62mg/5ml SF oral suspension
0501013K0BDACAG
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranclav 375mg tablets
0501013K0BDAAAA
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranclav 625mg tablets
0501013K0BDABAJ
|
Ranclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | No data available |
|
Ranfaxine XL 75mg capsules
0403040W0BQAAAD
|
Ranfaxine | Venlafaxine | Central Nervous System | No data available |
|
Ranflutin 20mg capsules
0403030E0BEAAAA
|
Ranflutin | Fluoxetine hydrochloride | Central Nervous System | No data available |
|
Ranibizumab 1.65mg/0.165ml inj pre-filled syringes
1108020ADAAACAC
|
Ranibizumab | Ranibizumab | Eye | No data available |
|
Ranibizumab 2.3mg/0.23ml solution for injection vials
1108020ADAAABAB
|
Ranibizumab | Ranibizumab | Eye | No data available |
|
Ranibizumab 3mg/0.3ml solution for injection vials
1108020ADAAAAAA
|
Ranibizumab | Ranibizumab | Eye | No data available |
|
Ranicalm 75mg tablets
0103010T0BWAAAP
|
Ranicalm | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitic 150mg tablets
0103010T0BHAAAA
|
Ranitic | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitic 300mg tablets
0103010T0BHABAC
|
Ranitic | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine 1.5mg/5ml oral liquid
0103010T0AAAZAZ
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.